PropertyValue
?:abstract
  • A compelling body of evidence points to pulmonary thrombosis and thromboembolism as a key feature of COVID-19. As the pandemic spread across the globe over the past few months, a timely call to arms was issued by a team of clinicians to consider the prospect of long-lasting pulmonary fibrotic damage and plan for structured follow-up. However, the component of post-thrombotic sequelae has been less widely considered. Although the long-term outcomes of COVID-19 are not known, should pulmonary vascular sequelae prove to be clinically significant, these have the potential to become a public health problem. In this Personal View, we propose a proactive follow-up strategy to evaluate residual clot burden, small vessel injury, and potential haemodynamic sequelae. A nuanced and physiological approach to follow-up imaging that looks beyond the clot, at the state of perfusion of lung tissue, is proposed as a key triage tool, with the potential to inform therapeutic strategies.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1016/s2213-2600(20)30407-0
?:journal
  • Lancet_Respir_Med
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/2ddffefcead039c78cf1e273d7e63e1b75e98a9f.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7833494.xml.json
?:pmcid
?:pmid
?:pmid
  • 33217366.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19
?:type
?:year
  • 2020-11-17

Metadata

Anon_0  
expand all